Literature DB >> 11258753

Evidence for the relation of herpes simplex virus type 1 to Down syndrome and Alzheimer's disease.

M S Cheon1, M Bajo, T Gulesserian, N Cairns, G Lubec.   

Abstract

The peripheral and central nervous system are harbouring herpes simplex virus type 1 (HSV-1) and this virus has been proposed to be implicated in the aetiology of Alzheimer's disease (AD). We tested whether the HSV-1 genome is found indeed in the brain of controls, patients with AD and Down syndrome (DS) and whether HSV-1 infectious proteins in brain were induced. Moreover, we tested whether interleukin (IL)-6, a marker for neuroinflammation, is found in brains of AD and DS. HSV-1 glycoprotein D gene, as well as viral phosphoprotein and glycoprotein were detected in all brain samples. IL-6 was detectable in seven out of the eight AD and all of the eight DS patients, but only three out of ten controls in the frontal cortex. IL-6 in cerebellum was detectable in all AD and DS patients, but only three out of nine controls. In conclusion, we propose that the detection of HSV-1 genome and HSV-1 inducible protein IL-6 not only shows the presence in human brain, but may indicate a role for HSV-1 in the process of neuroinflammation and apoptosis, known to occur in both neurodegenerative disorders, AD and DS.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11258753     DOI: 10.1002/1522-2683(200102)22:3<445::AID-ELPS445>3.0.CO;2-8

Source DB:  PubMed          Journal:  Electrophoresis        ISSN: 0173-0835            Impact factor:   3.535


  10 in total

Review 1.  Apolipoprotein E alleles can contribute to the pathogenesis of numerous clinical conditions including HSV-1 corneal disease.

Authors:  James M Hill; Partha S Bhattacharjee; Donna M Neumann
Journal:  Exp Eye Res       Date:  2006-09-26       Impact factor: 3.467

2.  Past exposure to vaccines and subsequent risk of Alzheimer's disease.

Authors:  R Verreault; D Laurin; J Lindsay; G De Serres
Journal:  CMAJ       Date:  2001-11-27       Impact factor: 8.262

3.  Neuronal activity regulates viral replication of herpes simplex virus type 1 in the nervous system.

Authors:  Cheryl X Zhang; Harrison Ofiyai; Ming He; Xuexian Bu; Yanhua Wen; William Jia
Journal:  J Neurovirol       Date:  2005-07       Impact factor: 2.643

Review 4.  Can infections cause Alzheimer's disease?

Authors:  Francis Mawanda; Robert Wallace
Journal:  Epidemiol Rev       Date:  2013-01-24       Impact factor: 6.222

5.  Alzheimer's disease gene signature says: beware of brain viral infections.

Authors:  Elisa Porcellini; Ilaria Carbone; Manuela Ianni; Federico Licastro
Journal:  Immun Ageing       Date:  2010-12-14       Impact factor: 6.400

6.  Human herpesvirus infections and dementia or mild cognitive impairment: a systematic review and meta-analysis.

Authors:  Charlotte Warren-Gash; Harriet J Forbes; Elizabeth Williamson; Judith Breuer; Andrew C Hayward; Angelique Mavrodaris; Basil H Ridha; Martin N Rossor; Sara L Thomas; Liam Smeeth
Journal:  Sci Rep       Date:  2019-03-18       Impact factor: 4.379

Review 7.  Persistent Infection with Herpes Simplex Virus 1 and Alzheimer's Disease-A Call to Study How Variability in Both Virus and Host may Impact Disease.

Authors:  Colleen A Mangold; Moriah L Szpara
Journal:  Viruses       Date:  2019-10-20       Impact factor: 5.048

Review 8.  Herpes Simplex Virus Type 1 and Other Pathogens are Key Causative Factors in Sporadic Alzheimer's Disease.

Authors:  Steven A Harris; Elizabeth A Harris
Journal:  J Alzheimers Dis       Date:  2015       Impact factor: 4.472

Review 9.  Molecular Mechanisms for Herpes Simplex Virus Type 1 Pathogenesis in Alzheimer's Disease.

Authors:  Steven A Harris; Elizabeth A Harris
Journal:  Front Aging Neurosci       Date:  2018-03-06       Impact factor: 5.750

Review 10.  Application of proteomics technology for analyzing the interactions between host cells and intracellular infectious agents.

Authors:  Mayte Coiras; Emilio Camafeita; María Rosa López-Huertas; Enrique Calvo; Juan Antonio López; José Alcamí
Journal:  Proteomics       Date:  2008-02       Impact factor: 3.984

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.